China SXT Pharmaceuticals Inc.
SXTC | NASDAQ
$2.93
-$0.05 (-1.68%)
At close: Nov 5, 2026, 4:00 PM ET
$2.86
-$0.07 (-2.39%)
After-hours:
Nov 5, 2026, 7:59 PM ET
Fiscal Quarter Period Ending | Q4 2026 Mar 31, 2026 | Q3 2026 Dec 31, 2025 | Q2 2026 Sep 30, 2025 | Q1 2026 Jun 30, 2025 | Q4 2025 Mar 31, 2025 | Q3 2025 Dec 31, 2024 | Q2 2025 Sep 30, 2024 | Q1 2025 Jun 30, 2024 | Q4 2024 Mar 31, 2024 | Q3 2024 Dec 31, 2023 | Q2 2024 Sep 30, 2023 | Q1 2024 Jun 30, 2023 | Q4 2023 Mar 31, 2023 | Q3 2023 Dec 31, 2022 | Q2 2023 Sep 30, 2022 | Q1 2023 Jun 30, 2022 | Q4 2022 Mar 31, 2022 | Q3 2022 Dec 31, 2021 | Q2 2022 Sep 30, 2021 | Q1 2022 Jun 30, 2021 | Q4 2021 Mar 31, 2021 | Q3 2021 Dec 31, 2020 | Q2 2021 Sep 30, 2020 | Q1 2021 Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.2M | 255.74K | 626.57K | -1.01M | 455.71K | 455.71K | 414.75K | 414.75K | 4.38M | 751.07K | 898.16K | 469.79K | 820.94K | 381.7K | 1.21M | 604.14K | 4.49M | 787.3K | 2.47M | 513.84K | 3.45M | 2.14M | 1.93M | 1.93M |
Cost of Revenue | 364.5K | 182.25K | 524.85K | -182.25K | 339.37K | 339.37K | 347.37K | 347.37K | 361.64K | 361.64K | 753.99K | 325.62K | 426.8K | 213.4K | 1.12M | 559.3K | 4.03M | 323.46K | 703.72K | 351.86K | 3.44M | 449.23K | 519.78K | 519.78K |
Gross Profit | 833.97K | 73.49K | 101.72K | -825.9K | 116.34K | 116.34K | 67.38K | 67.38K | 4.02M | 389.43K | 144.17K | 144.17K | 394.13K | 168.29K | 89.68K | 44.84K | 463.84K | 463.84K | 1.77M | 161.98K | 9.31K | 1.69M | 1.41M | 1.41M |
Operating Income | -784.01K | -392K | -6.34M | -3.17M | -1.02M | -1.02M | -319.13K | -319.13K | 265.63K | 3.42M | -4.67M | -4.67M | -1.83M | -2.23M | -1.15M | -575.22K | -1.15M | -1.15M | -1.45M | -1.45M | -1.68M | n/a | 581.91K | 581.91K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 168.26K | 46.25K | 46.25K | 192.14K | 192.14K | n/a | 18.38K | 34 | 35 | n/a | n/a | n/a | n/a |
Pretax Income | -1.21M | 81.86K | -6.37M | 1.42M | -1.25M | -1.25M | -401.28K | -401.28K | -7.62M | 2.79M | -90.73K | -4.84M | 293.89K | -2.22M | -747.3K | -747.31K | -27.37M | -1.32M | -2.83M | -1.38M | -15.06M | -3.96M | 499.36K | 808.14K |
Net Income | 163.72K | 81.86K | -6.37M | -81.86K | -1.25M | -1.25M | -401.28K | -401.28K | 3.3M | 3.3M | -4.85M | -4.85M | -2.22M | -2.22M | -1.49M | -747.31K | -2.64M | -1.32M | -3.09M | -1.55M | -2.06M | -2.06M | 690.63K | 690.63K |
Selling & General & Admin | 1.37M | 465.5K | 6.44M | 3.22M | 1.14M | 1.14M | 386.51K | 386.51K | 3.75M | 3.75M | 4.82M | 4.82M | 2.22M | 2.22M | 620.07K | 620.07K | 1.61M | 1.61M | 1.61M | 1.61M | 1.69M | 1.69M | 828.56K | 828.56K |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 244K | n/a | n/a | -4.44M | n/a | n/a | n/a | n/a | n/a | -6.78M | n/a | n/a | n/a | 174.7K | 620.07K | n/a | n/a | n/a | 1.61M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.62M | 465.49K | 6.44M | -1.22M | 1.14M | 1.14M | 386.51K | 386.51K | 3.75M | -3.03M | 4.82M | 4.82M | 2.22M | 2.4M | 1.24M | 620.07K | 1.61M | 1.61M | 3.22M | 1.61M | 1.69M | 1.69M | 828.56K | 828.56K |
Interest Expense | 31.64K | 15.82K | 31.33K | -15.82K | 232.88K | 232.88K | 91.24K | 91.24K | 207.76K | 103.88K | 336.52K | n/a | 92.49K | n/a | 384.29K | n/a | 3.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 686.99K | 102.78K | n/a | 19.31K | 119.62K | 119.62K | 25.31K | 25.31K | 128.31K | 128.31K | 88.48K | 88.48K | 57.64K | 57.64K | 136.08K | 136.08K | 263.86K | 263.86K | 198.41K | 198.41K | 441.39K | 441.39K | 352.28K | 352.28K |
Cost & Expenses | 1.98M | 647.75K | 6.97M | -1.4M | 1.48M | 1.48M | 733.88K | 733.88K | 4.11M | -2.67M | 5.57M | 5.14M | 2.65M | 2.61M | 2.36M | 1.18M | 5.64M | 1.94M | 3.92M | 1.96M | 5.13M | 2.14M | 1.35M | 1.35M |
Income Tax Expense | -1.37M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.92M | -513.23K | 4.76M | 5.31K | 2.51M | n/a | 4 | n/a | -24.72M | 1.18K | 263.04K | 162.89K | -12.99M | -1.89M | -191.27K | 117.51K |
Shares Outstanding (Basic) | 5.86K | 5.86K | 7.74K | n/a | 24.43K | 24.43K | 4.04K | 4.04K | 12.33K | 8.67K | 5.02K | 5.02K | 4.32K | 4.32K | 1.02K | 1.02K | 521 | 521 | 311 | 311 | 288 | 288 | 288 | 288 |
Shares Outstanding (Diluted) | 5.86K | 5.86K | 7.74K | n/a | 24.43K | 24.43K | 4.04K | 4.04K | 12.33K | 8.67K | 5.02K | 5.02K | 4.32K | 4.32K | 1.02K | 1.02K | 521 | 521 | 311 | 311 | 288 | 288 | 288 | 288 |
EPS (Basic) | 14 | 14 | -823 | n/a | -51 | -51 | -99 | -99 | 267 | 267 | -967 | -967 | -514 | -514 | -730 | -730 | -2.54K | -2.54K | -4.97K | -4.97K | -7.17K | -7.17K | 2.4K | 2.4K |
EPS (Diluted) | 14 | 14 | -823 | n/a | -51 | -51 | -99 | -99 | 267 | 380 | -967 | -967 | -514 | -514 | -730 | -730 | -2.54K | -2.54K | -4.97K | -4.97K | -7.17K | -7.17K | 2.4K | 2.4K |
EBITDA | -672.89K | -336.45K | -6.31M | 336.45K | -1.01M | -1.01M | -250.6K | -240.64K | 366.13K | 3.72M | -4.57M | -4.62M | -1.69M | -1.97M | -465.26K | -520.24K | -1.02M | -1.08M | -1.35M | -1.35M | -1.52M | 81.24K | 764.83K | 673.37K |
EBIT | -784.01K | -392.01K | -6.34M | 392.01K | -1.02M | -1.02M | -319.13K | -319.13K | 265.63K | 3.63M | -4.67M | -4.67M | -1.83M | -2.05M | -575.22K | -575.22K | -1.15M | -1.15M | -1.45M | -1.45M | -1.68M | n/a | 581.91K | 581.91K |
Depreciation & Amortization | 111.12K | 55.56K | 32.1K | -55.56K | 13.76K | 6.88K | 68.54K | 78.5K | 100.5K | 90.28K | 102.75K | 51.38K | 140.2K | 82.1K | 109.97K | 54.98K | 134.01K | 67K | 93K | 93K | 162.49K | 81.24K | 182.93K | 91.46K |
Add to Watchlist
Select watchlists to add or remove SXTC